171 related articles for article (PubMed ID: 7113038)
1. [Comparative evaluation of the effect of diet, pharmaco- and balneotherapy on a number of metabolic indices in obesity].
Lukasheva MV; Mokina MN
Vopr Kurortol Fizioter Lech Fiz Kult; 1982; (3):46-50. PubMed ID: 7113038
[No Abstract] [Full Text] [Related]
2. [The effect of adebit on carbohydrate and insulin metabolism in childhood obesity].
Blatniczky L; Kautzky L; Péter F
Orv Hetil; 1986 Jun; 127(23):1381-4, 1387-8. PubMed ID: 3523380
[No Abstract] [Full Text] [Related]
3. [Effect of metformin on glucose tolerance and insulin binding in semistarved obese women].
Zancanaro C; Cigolini M; Bertoldi P; Mezzena G; Giacomoni P; Bosello O
Minerva Endocrinol; 1984; 9(2):297-301. PubMed ID: 6390142
[No Abstract] [Full Text] [Related]
4. [The importance of the biguanides in the treatment of obesity].
Bittnerová H; Masek J; Rath R
Z Gesamte Inn Med; 1969 Mar; 24(5):139-42. PubMed ID: 5785830
[No Abstract] [Full Text] [Related]
5. [Results of a clinical study of a group of hospitalized diabetics under treatment with depot buformin].
Durante F; Scaffidi A; Rotolo G; Rini GB
Minerva Med; 1978 May; 69(24):1665-72. PubMed ID: 662170
[No Abstract] [Full Text] [Related]
6. Short-term effect of buformin, a biguanide, on insulin sensitivity, soluble fraction of tumor necrosis factor receptor and serum lipids in overweight patients with type 2 diabetes mellitus.
Ohara S; Komatsu R; Matsuyama T
Diabetes Res Clin Pract; 2004 Nov; 66(2):133-8. PubMed ID: 15533580
[TBL] [Abstract][Full Text] [Related]
7. [Clinical use of a new hypoglycemic agent: buformin].
Leone S; Modicano V; Scapellato L
Clin Ter; 1976 Sep; 78(6):527-35. PubMed ID: 1017159
[No Abstract] [Full Text] [Related]
8. [Behavior of IRI and some blood lipid indices after buformin administration].
Quartarone M; Saitta A; Caruso G; Monacciani U; Perdichizzi G; Squadrito G
Minerva Med; 1979 May; 70(22):1623-8. PubMed ID: 450301
[No Abstract] [Full Text] [Related]
9. [The potentials for the balneotherapy of obesity using arsenic-containing mineral water].
Ivanov EM; Antoniuk MV
Vopr Kurortol Fizioter Lech Fiz Kult; 1998; (3):11-4. PubMed ID: 9771136
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of diabetic fatty liver with Buformin].
Möller E
Med Klin; 1967 Dec; 62(48):1873-6. PubMed ID: 5591974
[No Abstract] [Full Text] [Related]
11. [Inhibition of the transplacental blastomogenic effect of N-nitrosomethylurea in rats by buformin].
Anisimov VN; Aleksandrov VA; Belous NM; Vasil'eva IA; Matson VB
Biull Eksp Biol Med; 1980 Jul; 89(7):88-90. PubMed ID: 6996759
[TBL] [Abstract][Full Text] [Related]
12. [Joly JP: [Obesity and fast therapy. Immediate and long-term reducing]].
Schrub JC; Hillemand B; Dubuisson M
Sem Hop; 1971 Jan; 47(4):217-27. PubMed ID: 4322129
[No Abstract] [Full Text] [Related]
13. Treatment of reactive hypoglycemia with buformin.
Sekso M; Solter M; Zjacić V; Cabrijan T
Am J Clin Nutr; 1975 Nov; 28(11):1271-6. PubMed ID: 1190104
[TBL] [Abstract][Full Text] [Related]
14. [Comparative studies of the effect of N1-n-butylbiguanide hydrochloride (Buformin) and N1-n-butylbiguanide tosylate (Buformin retard)].
Singer P; Thoelke H
Z Gesamte Inn Med; 1973 Aug; 28(16):504-6. PubMed ID: 4767598
[No Abstract] [Full Text] [Related]
15. [Dynamics of lipid and carbohydrate metabolism in various methods of treatment of obesity].
Vasiukova EA; Olefirenko VT; Granovskaia-Tsvetkova AM; Vinogradova IM
Ter Arkh; 1979; 51(12):97-9. PubMed ID: 538727
[No Abstract] [Full Text] [Related]
16. [Diet with contrast and fat days in the balneotherapy of obesity].
Kolominský J; Doberský P
Fysiatr Revmatol Vestn; 1967 Jun; 45(3):136-44. PubMed ID: 5634211
[No Abstract] [Full Text] [Related]
17. [External respiratory function based on capnographic data during radon bath treatment of patients with exogenous-constitutional obesity].
Amirov RZ; Mukharamova GA
Vopr Kurortol Fizioter Lech Fiz Kult; 1987; (3):55-7. PubMed ID: 3114951
[No Abstract] [Full Text] [Related]
18. [Correction of endocrine-metabolic disorders in oncologic patients. The effect of biguanides (phenformin and adebita), miskleron and diphenin].
Dil'man VM; Bershteĭn LM; Tsyrlina EV; Bobrov IuF; Kovaleva IG
Vopr Onkol; 1975; 21(11):33-9. PubMed ID: 1210118
[TBL] [Abstract][Full Text] [Related]
19. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
[TBL] [Abstract][Full Text] [Related]
20. [The biguanides-insulin combination in the treatment of certain types of diabetes].
Leng-Lévy J; Leng B; Aubertin J; Lacut JY; Le Gall F; Boget JC; Lenoir MP
Bord Med; 1972 Dec; 5(19):2659-64. PubMed ID: 4659799
[No Abstract] [Full Text] [Related]
[Next] [New Search]
